Targeting Peptides are a class of short peptide molecules that can specifically recognize certain cells, tissues, or pathological microenvironments. They are widely applied in cutting-edge fields such as drug delivery, molecular imaging, targeted diagnosis, and therapy. We offer one-stop customized Targeting Peptide synthesis services, covering sequence design, modified synthesis, conjugation construction, purification and analysis, as well as functional expansion, supporting various functional groups and carrier systems. Leveraging a mature peptide synthesis platform and a stringent quality control system, we are committed to providing customers with Targeting Peptide solutions that feature high purity, high stability, and excellent adaptability, accelerating research and drug development processes. As a professional peptide service provider, we offer you one-stop customized Targeting Peptide synthesis services to meet diverse needs from research to industrialization.
Provide Targeting Peptide sequence suggestions based on target characteristics (e.g., tumor tissue, inflammatory cells, blood-brain barrier)
Optimize affinity and stability through literature research, structural modeling, or AI prediction
Offer custom-designed sequences or optimization advice for client-provided sequences
Support solid-phase peptide synthesis (SPPS) for peptides ranging from 5 to 100 amino acids
Multiple purity grades available (Standard >75%, Research Grade >90%, High Purity >95%)
High-throughput synthesis capability, suitable for parallel multi-sequence orders
N--terminal modifications/C-terminal modifications: acetylation, amidation, phosphorylation, sulfation, etc.
Label modifications: FITC, Cy5, DOTA, etc.
Drug conjugation: DOX, MMAE, cisplatin, and other anticancer drugs
Carrier conjugation: covalent binding with liposomes, PLGA nanoparticles, gold nanoparticles, antibodies, proteins, etc.
PEGylation (various molecular weights): extends in vivo half-life and reduces immunogenicity
RP-HPLC high-efficiency purification
Comprehensive test reports including HPLC, MS, LC-MS data
GMP-grade products available upon request (for preclinical or regulatory support)
Various delivery formats: lyophilized powder, vial aliquots, solutions in specific buffers
Provide COA, QC reports, TDS, and other technical documentation
Accept orders from milligrams to grams, supporting rapid prototyping and scale-up production
Construction of Targeting Peptide-therapeutic peptide chimeras (e.g., RGD-antimicrobial peptides, iRGD-proapoptotic peptides)
Cell targeting capability validation experiments (cell uptake, binding efficiency)
Custom bio-probes/imaging peptides (MRI, fluorescence, radioactive labeling, etc.)
We are committed to providing high-quality, customizable Targeting Peptide solutions for global research and industrial clients.
Client provides targeted sequence or target information (e.g., target, tissue type)
Our technical staff assists in confirming synthesis plans, modification methods, purity requirements, etc.
Provide synthesis feasibility analysis
Offer formal quotation, timeline assessment, and delivery format explanation
Solid-phase peptide synthesis (SPPS) + required functional modifications (e.g., labeling, PEGylation, conjugation)
Multi-step quality control testing to ensure product quality
HPLC purification with selectable purity levels >90%, >95%, >98%
Testing methods include HPLC, MS, LC-MS, etc.
Lyophilized powder or solution forms, customized packaging according to client needs
Provide COA, TDS, chromatograms, and complete technical documentation
Usage recommendations and storage instructions provided
Accept client feedback and promptly respond to technical inquiries
Peptides that specifically bind to target cells or tissues enhance the precision and efficacy of drug delivery in cancer, inflammation, and infectious diseases.
Conjugated with fluorescent, radioactive, or MRI probes, Targeting Peptides enable high-sensitivity imaging and accurate disease detection.
Used to functionalize nanoparticles, liposomes, polymers, or viral vectors for improved delivery of drugs or nucleic acids.
Deliver antigens specifically to immune cells to boost vaccine efficacy and immune responses.
Enhance targeted delivery and cellular uptake of nucleic acid therapeutics like mRNA, siRNA, or CRISPR components.
Special peptides facilitate drug transport across the BBB for treatment of central nervous system disorders.